Skip to main content

Pathogen and Graphene

Objective

Complications related to infectious diseases have significantly reduced, particularly in the developed countries, due to the availability and use of broad-range antibiotics and wide variety of antimicrobial agents. Excessive use of antibiotics and antimicrobial agents increased significantly the number of multi-drug resistant (MDR) bacteria. This has resulted in a serious threat to public health. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the low rate of emergence of new clinically useful antibiotics, has refocused attention on finding alternatives to overcome antimicrobial resistance. Novel strategies aiming to reduce the amount of antibiotics, but able to prevent and treat animal and human infections should be investigated, evidenced and approved. Among the various approaches, the use of graphene and its derivatives is currently considered a highly promising strategy to overcome microbial drug resistance.

In line with this interest in graphene by the European Commission through the graphene ‘flagship’ initiatives, we respond in this consortium by exploring the utility of novel graphene based nanocomposites for the management and better understanding of microbial infections. The anti-microbical potential of the novel graphene based nanomaterials, the possibility of using such structures for the development of non-invase therapies together with the understanding of the mechanism of action will be the main focal points of the proposed project entitled “PANG”, relating to Pathogen and Graphene.

We have gathered the essential elements, namely different academic institutions in Europe (France, Germany, and Sweden) and their associated countries (Ukraine) as well as two European companies (Graphenea-Spain and LSO Medical-France) and one company (RS RESEARCH) in one of the associated countries (Turkey). The proposed multidisciplinary project uniquely suits high-level interdisciplinary and cross-border training.

Field of science

  • /medical and health sciences/health sciences/public and environmental health
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance
  • /medical and health sciences/health sciences/infectious disease
  • /engineering and technology/nanotechnology/nano-materials/two-dimensional nanostructures/graphene
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/multidrug resistance
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance

Call for proposal

H2020-MSCA-RISE-2015
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

UNIVERSITE DE LILLE
Address
42 Rue Paul Duez
59800 Lille
France
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 108 000

Participants (7)

RUHR-UNIVERSITAET BOCHUM
Germany
EU contribution
€ 72 000
Address
Universitaetsstrasse 150
44801 Bochum
Activity type
Higher or Secondary Education Establishments
UNIVERSITATSKLINIKUM ERLANGEN
Germany
EU contribution
€ 45 000
Address
Maximiliansplatz 2
91054 Erlangen
Activity type
Higher or Secondary Education Establishments
GOETEBORGS UNIVERSITET
Sweden
EU contribution
€ 22 500
Address
Vasaparken
405 30 Goeteborg
Activity type
Higher or Secondary Education Establishments
LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO
Ukraine
EU contribution
€ 76 500
Address
69 Pekarska Street
79010 Lviv
Activity type
Higher or Secondary Education Establishments
GRAPHENEA SA
Spain
EU contribution
€ 49 500
Address
Paseo Mikeletegi 83
20009 San Sebastian Guipuzcoa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LSO MEDICAL
France
EU contribution
€ 49 500
Address
280 Rue Salvador Allende
59120 Loos
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI
Turkey
EU contribution
€ 157 500
Address
Sanayi Mah Teknopark Blv. Teknopark 2A Apt No 1/2A
34906 Istanbul
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)